Drug and Alcohol Dependence 1999: Vol 55 Index

5 Pages·1999·0.97 MB·English

ELSEVIER
Drug and Alcohol Dependence 55 (1999) 277
Author index
Volume 55 (1999)
Adelson, M. Garcia-Gil, L. 55, 127 Ramos, J.A.
A. Meisch,R Gastfriend, D.R. 55, 35 Regan, C.M.
Aaumaneen, 8 Gelkopf, M. 55, 63 Reif, S.
Anthony, J.C. Giesbrecht, N. 55, 53 Ring-Kurtz, S. 55, 235
Arasteh, K. Gilvarry, E. 55, 263 Roche, A. 55, 105
Gollnisch, G. 55, 145 Romero, J. 55, 127
Baker, R.W. Gould, F. 55, 91 Roset, P.N. 55, 117
Bauman, A. Grant, K.A. 55, 13 Rush, C.R. 55, |
Baumann, P. Gutowski, W.E. 55, 35 Rutherford, M. 55, 235
Belding, M.A.
Bencivengo, M. Hagan, T.A. 55, 91, 235 Schottenfeld, R.S.
Bleich, A. 55, Hando, J. 55, 105 Silas Obot, |. 55, 177
Bodner, G. 55, Hayward, R. 55, 63
Solowij, N. 55, 105
Booth, R.E. 55, 69 Hubbard, S. 55, 177
Storr, C.L. 55, 45
Bowen, C.A. 55, 13
B. Stewart, R. 55, 79 Iguchi, M.Y. 55, 25 Swadi, H. 55, 209
Jaffe, J. 55, 91 Tarter, R.E.
Cami, J. 55, 117
Topp, L. 55, 105
Chawarski, M.C.
Kirisci, L. 55, 165 Trinkoff, A.M.
Cherpitel, C.J.
Kwiatkowski, C.F. 55, 69 Turner, K.H.
Christian, J.
Turner, W.M.
Collins, R.L.
Levine, M. 55, 91
Cox, W.M.
Uehlinger, C.
Crome, 1B.
Macdonald, S.
McLellan, A.T. 55, 91, 235 Wang, N.-s.
Dawes, M.A.
Meyers, K. 55, 91, 235 Webb, A.
Dillon, P.
DDuorrenl,l , LJ. D. MMMooorsrrssa,hl e,i Hm.eABr..,R . E5.5T,5 .5 ,1 62555 5 , 145 WWeeilslssm,Sa .n ,
Wright, K.
Eap, C.B. O'Connor, P.G. 55, 157
Yao, J.K.
Farré, M. Pakes, J. 55, 157 Yeates, G.N
Felder, C. Phongsavan, P. 55, 187
Fernandez-Ruiz, J.J. Poudevida, S. 55, 117
Frantz, J. 55, 235 Powell, K. 55, 137 Zeitlin, H.
PII: $0376-8716(99)00038-1

ELSEVIER
Drug and Alcohol Dependence 55 (1999) 279-281
Subject index
Volume 55 (1999)
Addiction; Algorithm: Automation: Criteria; Matching: Substance Benzodiazepines; Methadone maintenance: Sedatives; IDU; Fluni-
abuse 55, 35 trazepam; Oxazepam; Diazepam: Motivation; Substance abuse 535,
63
Addiction; Bioavailability; Enantiomer: Health: Intravenous: Metha-
done; Oral 55, 137 Bioavailability; Addiction; Enantiomer: Health; Intravenous; Metha-
done: Oral 55, 137
Addiction; Outpatient: Clinical case management 55, 91
Buprenorphine, Plasma level: Substance abuse; Opioid mainte-
Addiction Research Center Inventory (ARC1): Spanish version: Subjec- nance 55, 157
tive effects: Sedatives: Stimulants: Opioids: Drug abuse 55, 117
Cannabinoid receptor binding: Cannabinoids; 4°-Tetrahydrocan-
Adolescent; Risk factors; Substance use 55, 209 nabinol; Perinatal exposure: Cannabinoid receptor MRNA levels 55,
127
Adolescents; Assessment: Measurement: Substance abuse: Comprehen-
sive Adolescent Severity Inventory 55, 235 Cannabinoid receptor mRNA levels; Cannabinoids; 4°’-Tetrahydrocan-
nabinol; Perinatal exposure; Cannabinoid receptor binding 55, 127
Adolescent: Substance misuse: Treatment interventions: Outcome 55,
247 Cannabinoids: 4°’-Tetrahydrocannabinol: Perinatal exposure; Can-
nabinoid receptor binding: Cannabinoid receptor mRNA levels 55,
127
Adolescent: Substance use: Tobacco: Alcohol: Prevalence: Epidemiol-
ogy 55, 187
Clinical case management: Outpatient: Addiction 55, 91
African Americans: Injecting drug use: School dropout: IDU:; IVDU:
Cocaine: Humans: Drug abuse: Physiological effects; Behavioral ef-
Level of education: Epidemiology 55, 177
fects 55, |
Alcohol, Adolescent: Substance use: Tobacco: Prevalence: Epidemiol- Cognitive processing: Alcohol: Drinkers: Alcohol cues: Stroop
ogy 55, 187
paradigm 55, 85
Alcohol; Cognitive processing: Drinkers: Alcohol cues: Stroop
Comorbid disorders: Substance misuse: Early identification and treat-
paradigm 55, 85 ment 55, 225
Alcohol consequences; Nurses: Women; Prevalence: Substance use 55, Comprehensive Adolescent Severity Inventory: Adolescents; Assess-
145
ment: Measurement: Substance abuse 55, 235
Alcohol cues; Cognitive processing: Alcohol: Drinkers: Stroop Criteria; Addiction; Algorithm: Automation; Matching: Substance
paradigm 55, 85 abuse 55, 35
Algorithm: Addiction: Automation; Criteria; Matching; Substance Diazepam: Methadone maintenance; Benzodiazepines; Sedatives; IDU:
abuse 55, 35 Flunitrazepam; Oxazepam: Motivation; Substance abuse 55, 63
Assessment; Adolescents: Measurement; Substance abuse: Comprehen- Drinkers; Cognitive processing: Alcohol; Alcohol cues; Stroop
sive Adolescent Severity Inventory 55, 235 paradigm 55, 85
Automation; Addiction: Algorithm: Criteria: Matching: Substance Drug abuse; Addiction Research Center Inventory (ARCI); Spanish
abuse 55, 35 version: Subjective effects; Sedatives: Stimulants; Opioids 55, 117
Behavioral effects: Cocaine: Humans: Drug abuse: Physiological ef- Drug abuse; Cocaine: Humans; Physiological effects; Behavioral ef-
fects 55, | fects 55, 1
PII: $0376-8716(99)00039-3
280 Subject index
Drug discrimination: Ethanol: Pentobarbital: GABA , positive modula- Injuries; Drug metabolites; Substance use 55, 53
tors: NMDA antagonists: 5-HT, agonists: Isopropanol: rat 55, 13
Intervention preferences; Ecstasy: Patterns of use; Polydrug use:
Drug metabolites: Injuries: Substance use 55, 53 Harm 55, 105
Drug users; HIV infected: Risk behaviors: Health-related service Intravenous; Addiction; Bioavailability; Enantiomer: Health; Metha-
utilization 55, 69 done; Oral 55, 137
Early identification and treatment: Substance misuse; Comorbid disor- Isopropanol; Ethanol; Pentobarbital; GABA, positive modulators;
ders 55, 225 NMDA antagonists: 5-HT, agonists: Drug discrimination; rat 55, 13
Eestasy; Patterns of use: Polydrug use: Harm; Intervention prefer- IVDU; Injecting drug use; School dropout; IDU; African Americans;
ences 55, 105 Level of education; Epidemiology 55, 177
Enantiomer, Addiction: Bioavailability: Health; Intravenous; Metha- Job strain; Occupational health: Stress: Substance abuse; Survey 55,
45
done: Oral 55, 137
Epidemiology: Adolescent; Substance use: Tobacco; Alcohol; Preva- Level of education; Injecting drug use: School dropout; IDU; IVDU;
lence 55, 187 African Americans; Epidemiology 55, 177
Epidemiology: Injecting drug use: School dropout: IDU; IVDU;: Matching: Addiction: Algorithm: Automation; Criteria: Substance
African Americans: Level of education 55, 177 abuse 55, 35
Measurement: Adolescents: Assessment: Substance abuse: Comprehen-
Ethanol; Pentobarbital; GABA, positive modulators; NMDA antago-
sive Adolescent Severity Inventory 55, 235
nists; 5-HT, agonists; Isopropanol; Drug discrimination; rat 55, 13
Methadone: Addiction: Bioavailability; Enantiomer: Health; Intra-
Family and peer dysfunction: Substance abuse liability: Hormonal and
venous; Oral 55, 137
behavioral homeostasis: Personality 55, 165
Methadone: Fixed-interval schedule: Naloxone: Oral self-administra-
Fixed-interval schedule: Methadone: Naloxone; Oral self-administra-
tion; Rhesus monkeys 55, 79
tion; Rhesus monkeys 55, 79
Methadone maintenance. Benzodiazepines: Sedatives; IDU: Fluni-
Flunitrazepam: Methadone maintenance: Benzodiazepines; Sedatives:
trazepam: Oxazepam: Diazepam: Motivation: Substance abuse 55, 63
IDU: Oxazepam: Diazepam: Motivation: Substance abuse 55, 63
Methadone maintenance therapy: Substance abuse treatment; Treat-
GABA, positive modulators; Ethanol: Pentobarbital;: NMDA antago-
ment outcomes; Prognosis: Urinalyses 55, 25
nists; 5-HT, agonists; Isopropanol; Drug discrimination; rat 55, 13
Motivation: Methadone maintenance; Benzodiazepines; Sedatives:
Harm: Ecstasy; Patterns of use: Polydrug use: Intervention prefer-
IDU; Flunitrazepam: Oxazepam: Diazepam: Substance abuse 55, 63
ences 55, 105
Naloxone; Fixed-interval schedule: Methadone: Oral self-administra-
Health; Addiction: Bioavailability; Enantiomer; Intravenous; Metha-
tion; Rhesus monkeys 55, 79
done: Oral 55, 137
NMDA antagonists; Ethanol; Pentobarbital; GABA, positive modula-
Health-related service utilization, HIV infected; Drug users: Risk
behaviors 55, 69 tors: 5-HT, agonists: lsopropanol; Drug discrimination; rat 55, 13
HIV infected: Drug users: Risk behaviors: Health-related service Nurses; Women: Prevalence: Substance use: Alcohol conse-
utilization 55, 69 quences 55, 145
Hormonal and behavioral homeostasis; Substance abuse liability: Per- Occupational health; Stress: Substance abuse: Survey: Job strain 55,
45
sonality; Family and peer dysfunction 55, 165
5-HT, agonists; Ethanol; Pentobarbital; GABA, positive modulators; Opioid maintenance: Buprenorphine; Plasma level; Substance
NMDA antagonists; Isopropanol; Drug discrimination; rat 55, 13 abuse 55, 157
Humans; Cocaine: Drug abuse; Physiological effects; Behavioral ef- Opioids; Addiction Research Center Inventory (ARCI); Spanish ver-
fects 55, | sion; Subjective effects; Sedatives: Stimulants: Drug abuse 55, 117
IDU: Injecting drug use: School dropout; IVDU; African Americans: Oral, Addiction; Bioavailability: Enantiomer; Health; Intravenous;
Level of education: Epidemiology 55, 177 Methadone 55, 137
IDU: Methadone maintenance: Benzodiazepines: Sedatives; Fluni- Oral self-administration; Fixed-interval schedule: Methadone: Nalox-
trazepam: Oxazepam; Diazepam; Motivation; Substance abuse 55, 63 one: Rhesus monkeys 55, 79
Injecting drug use; School dropout: IDU; IVDU; African Americans; Outcome; Adolescent: Substance misuse: Treatment interventions 55,
Level of education; Epidemiology 55, 177 247
Subject index 281
Outpatient; Addiction; Clinical case management 55, 91 Stroop paradigm; Cognitive processing: Alcohol; Drinkers; Alcohol
cues 55, 85
Oxazepam; Methadone maintenance; Benzodiazepines; Sedatives;
IDU; Flunitrazepam; Diazepam; Motivation; Substance abuse 55, 63 Subjective effects; Addiction Research Center Inventory (ARCI);
Spanish version; Sedatives; Stimulants; Opioids; Drug abuse 55, 117
Partnership: Substance misuse: Young people 55, 263
Substance abuse; Addiction; Algorithm; Automation; Criteria; Match-
Patterns of use: Ecstasy: Polydrug use: Harm; Intervention prefer- ing 55, 35
ences 55, 105
Substance abuse; Adolescents; Assessment; Measurement; Comprehen-
Pentobarbital; Ethanol; GABA, positive modulators; NMDA antago- sive Adolescent Severity Inventory 55, 235
nists; 5-HT, agonists; Isopropanol; Drug discrimination; rat 55, 13
Substance abuse; Buprenorphine; Plasma level: Opioid mainte-
nance 55, 157
Perinatal exposure; Cannabinoids; 4°-Tetrahydrocannabinol; Can-
nabinoid receptor binding: Cannabinoid receptor mRNA levels 55,
127 Substance abuse liability; Hormonal and behavioral homeostasis;
Personality; Family and peer dysfunction 55, 165
Personality; Substance abuse liability; Hormonal and _ behavioral
Substance abuse; Methadone maintenance; Benzodiazepines; Sedatives:
homeostasis; Family and peer dysfunction 55, 165
IDU; Flunitrazepam; Oxazepam; Diazepam; Motivation 55, 63
Physiological effects: Cocaine: Humans; Drug abuse: Behavioral ef-
Substance abuse; Occupational health; Stress; Survey: Job strain 55,
fects 55, 1 45
Plasma level; Buprenorphine: Substance abuse: Opioid mainte- Substance abuse treatment; Treatment outcomes; Prognosis; Metha-
nance §§5, 157
done maintenance therapy: Urinalyses 55, 25
Polydrug use: Ecstasy: Patterns of use; Harm; Intervention prefer- Substance misuse; Adolescent: Treatment interventions; Outcome 55,
ences 55, 105 247
Prevalence: Adolescent; Substance use; Tobacco; Alcohol: Epidemiol- Substance misuse; Comorbid disorders; Early identification and treat-
ogy 55, 187 ment 55, 225
Prevalence: Nurses: Women: Substance use; Alcohol conse- Substance misuse; Partnership: Young people 55, 263
quences 55, 145
Substance use; Adolescent; Tobacco; Alcohol; Prevalence; Epidemiol-
Prognosis: Substance abuse treatment; Treatment outcomes: Metha- ogy 55, 187
done maintenance therapy; Urinalyses 55, 25
Substance use: Drug metabolites: Injuries 55, 53
rat; Ethanol; Pentobarbital; GABA, positive modulators; NMDA
antagonists: 5-HT, agonists; lsopropanol; Drug discrimination 55, 13 Substance use: Nurses; Women: Prevalence: Alcohol conse-
quences 55, 145
Rhesus monkeys; Fixed-interval schedule: Methadone; Naloxone; Oral
self-administration 55, 79 Substance use: Risk factors; Adolescent 55, 209
Risk behaviors; HIV infected: Drug users: Health-related service Survey; Occupational health; Stress; Substance abuse; Job strain 55,
45
utilization 55, 69
A°-Tetrahydrocannabinol; Cannabinoids; Perinatal exposure; Can-
Risk factors: Adolescent: Substance use 55, 209
nabinoid receptor binding: Cannabinoid receptor mRNA levels 55,
127
School dropout: Injecting drug use; IDU; IVDU; African Americans;
Level of education: Epidemiology 55, 177
Tobacco: Adolescent; Substance use: Alcohol; Prevalence: Epidemiol-
ogy 55, 187
Sedatives; Addiction Research Center Inventory (ARCI); Spanish
version; Subjective effects; Stimulants; Opioids; Drug abuse 55, 117
Treatment interventions: Adolescent; Substance misuse: Outcome 55,
247
Sedatives; Methadone maintenance; Benzodiazepines; IDU; Fluni-
trazepam; Oxazepam; Diazepam: Motivation; Substance abuse 55, 63 Treatment outcomes; Substance abuse treatment; Prognosis; Metha-
done maintenance therapy; Urinalyses 55, 25
Spanish version; Addiction Research Center Inventory (ARCI); Subjec-
tive effects; Sedatives; Stimulants; Opioids; Drug abuse 55, 117 Urinalyses; Substance abuse treatment; Treatment outcomes; Progno-
sis; Methadone maintenance therapy 55, 25
Stimulants; Addiction Research Center Inventory (ARCI): Spanish
version; Subjective effects: Sedatives; Opioids; Drug abuse 55, 117 Women: Nurses: Prevalence; Substance use; Alcohol conse-
quences 55, 145
Stress; Occupational health; Substance abuse; Survey; Job strain 55,
45 Young people; Substance misuse; Partnership 55, 263